Interleukin-2 gene therapy of chronic neuropathic pain
- 30 May 2002
- journal article
- Published by Elsevier in Neuroscience
- Vol. 112 (2) , 409-416
- https://doi.org/10.1016/s0306-4522(02)00078-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglionGene Therapy, 2001
- INTERLEUKIN 2-INDUCED ANTINOCICEPTION PARTIALLY COUPLED WITH μ RECEPTORCytokine, 2000
- Gene Expression along the Cerebral-Spinal Axis after Regional Gene DeliveryHuman Gene Therapy, 1999
- A Paracrine Paradigm for in Vivo Gene Therapy in the Central Nervous System: Treatment of Chronic PainHuman Gene Therapy, 1999
- The Analgesic Domain of IL-2Biochemical and Biophysical Research Communications, 1997
- Interleukin-2 as a neuroregulatory cytokineBrain Research Reviews, 1995
- Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampusBrain Research, 1990
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPAIN®, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976